Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Epigenetics and Signaling Pathways in Glaucoma
Angela C. Gauthier, Ji Liu
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Epigenetics and Signaling Pathways in Glaucoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glaucoma
100%
Signaling Pathway
100%
Epigenetic Pathways
100%
Gene Expression
50%
Aging
50%
Rho Kinase
50%
Trabecular Meshwork
50%
Genetic Factors
50%
Epigenetics
50%
B-cell Lymphoma 2 (Bcl-2)
50%
Most Common Cause
50%
Environmental Factors
50%
Neurodegenerative Diseases
50%
Caspase
50%
Novel Therapeutics
50%
Human Trials
50%
Retinal Neurons
50%
Fibrosis
50%
New Drug Targets
50%
Neuroprotective
50%
Apoptotic Genes
50%
Mitogen-activated Protein Kinase
50%
Pro-survival
50%
Calpain
50%
PI-3
50%
Irreversible Blindness
50%
Aqueous Humor Drainage
50%
Medicine and Dentistry
Signal Transduction
100%
Glaucoma
100%
Epigenomics
100%
Gene Expression
50%
Isotopes of Calcium
50%
Rho Kinase
50%
Downregulation
50%
Trabecular Meshwork
50%
Therapeutic Agent
50%
Upregulation
50%
Amaurosis
50%
Environmental Factor
50%
Fibrosis
50%
Neuroprotective Agent
50%
Retinal Neuron
50%
Mitogen-Activated Protein Kinase
50%
Brain Derived Neurotrophic Factor
50%
Caspase
50%
Degenerative Disease
50%
Survival Factor
50%
Aqueous Humor Flow
50%
Calpain
50%
Pharmacology, Toxicology and Pharmaceutical Science
Glaucoma
100%
Neuroprotective Agent
50%
Caspase
50%
Fibrosis
50%
Degenerative Disease
50%
Calpain
50%
Mitogen Activated Protein Kinase
50%
Brain Derived Neurotrophic Factor
50%
Rho Kinase
50%
Survival Factor
50%